A new accelerator for advanced research and cancer therapy Ken Peach John Adams Institute.

Slides:



Advertisements
Similar presentations
EMMA Magnet Design Ben Shepherd Magnetics and Radiation Sources Group ASTeC STFC Daresbury Laboratory.
Advertisements

Manchester University and the Cockcroft Institute Roger Barlow Technologies manchester.ac.uk Accelerators for ADSRs An account of the requirements.
Accelerators 2006 Roger Barlow 1: Wakefields 2: The NS-FFAG.
Design and Performance Expectation of ALPHA accelerator S.Y. Lee, IU 2/26/ Introduction 2. Possible CIS re-build and parameters 3. Issues in the.
Accelerator Science Roger Barlow EPSRC Visit 6 th December 2007.
Welcome! BASROC/CONFORM Open Day Daresbury May 11 th 2009 Roger Barlow, Manchester University and the Cockcroft Institute.
EMMA: the first NS-FFAG Roger Barlow. What is an FFAG? Like a synchrotron Strong Focussing (‘Alternating Gradient’) Dipole field increases with particle.
Accelerators Ken Peach John Adams Institute for Accelerator Science Charters School 28.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme PAMELA: Concepts Particle Accelerator for MEdicaL Applications K.Peach(JAI,
FFAG Concepts and Studies David Neuffer Fermilab.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
FFAG Tune-stabilized, Linear-field Nonscaling FFAG Lattice Design C. Johnstone, Fermilab S. Koscielniak, TRIUMF FFAG07 April 12-17, 2007 LPSC, Grenoble,
Charged Particle Therapy: Physicists meet Physicians Ken Peach John Adams Institute for.
British Accelerator Science & Radiation Oncology Consortium A new.
A Laser Afternoon: Introduction Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin.
NON-SCALING FFAGs: questions needing answers Andy Wolski The Cockcroft Institute, and the University of Liverpool Department of Physics. BASROC-CONFORM.
March 2011Particle and Nuclear Physics,1 Experimental tools accelerators particle interactions with matter detectors.
S.J. Brooks RAL, Chilton, OX11 0QX, UK Options for a Multi-GeV Ring Ramping field synchrotron provides fixed tunes and small.
The EMMA Project Rob Edgecock STFC Rutherford Appleton Laboratory & Huddersfield University.
The EMMA Project Rob Edgecock STFC Rutherford Appleton Laboratory & Huddersfield University *BNL, CERN, CI, FNAL, JAI, LPSC Grenoble, STFC, TRIUMF.
2002/7/02 College, London Muon Phase Rotation at PRISM FFAG Akira SATO Osaka University.
2002/7/04 College, London Beam Dynamics Studies of FFAG Akira SATO Osaka University.
Y. Mori Kyoto/KEK FFAG C. OH FFAG: Fixed Field Alternating Gradient Strong focusing(AG focusing, phase focusing) Like synchrotron, but fixed field Moving.
The ISIS strong focusing synchrotron also at the Rutherford Appleton Laboratory. Note that ISIS occupies the same hall as NIMROD used to and re- uses some.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
The CONFORM project Roger Barlow BASROC launch 3 rd May 2007.
The Project : CONFORM is an RCUK-funded Basic Technology Programme Roger CONFORM Open Day 24th June 2010 CONFORM.
The Particle Therapy Cancer Research Institute is a member of the 4 th April 2013, PASI Workshop, RAL Ken Peach John Adams Institute for Accelerator Science.
1 Status of EMMA Shinji Machida CCLRC/RAL/ASTeC 23 April, ffag/machida_ ppt & pdf.
ADSRs and FFAGs Roger Barlow. 7 Jan 2008Workshop on ADSRs and FFAGsSlide 2 The ADSR Accelerator Driven Subcritical Reactor Accelerator Protons ~1 GeV.
28/04/2008 JAI Advisory Board Meeting NS-FFAG development at JAI PAMELA ( & EMMA ) Takeichiro Yokoi.
UK FFAG Plans Introduction to FFAGs Scaling vs non-scaling Non-scaling FFAGs Non-scaling POP Why the interest? UK plans.
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
Advanced Accelerator Design/Development Proton Accelerator Research and Development at RAL Shinji Machida ASTeC/STFC/RAL 24 March 2011.
, EUROnu Meeting, Strasbourg J. Pasternak Status and recent progress on muon IDS-FFAG J. Pasternak, Imperial College, London / RAL STFC Work.
J-PARC Accelerators Masahito Tomizawa KEK Acc. Lab. Outline, Status, Schedule of J-PARC accelerator MR Beam Power Upgrade.
Road Map of Future Neutrino Physics A personal view Ken Peach Round Table discussion at the 6 th NuFACT Workshop Osaka, Japan 26 th July – 1 st August.
FFAG Tune-stabilized, Linear-field FFAG C. Johnstone, Fermilab S. Koscielniak, TRIUMF FFAG06 Japan f Fermilab.
JAI-Diamond Joint Seminar 07/06/20071 Development of Non-Scaling FFAG : EMMA & PAMELA Takeichiro Yokoi J. Adams Institute Oxford University.
Design of an Isochronous FFAG Ring for Acceleration of Muons G.H. Rees RAL, UK.
1 FFAG Role as Muon Accelerators Shinji Machida ASTeC/STFC/RAL 15 November, /machida/doc/othertalks/machida_ pdf/machida/doc/othertalks/machida_ pdf.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
PAMELA an overview Takeichiro Yokoi JAI, Oxford University.
Part IV Applications. Prototype of Cancer therapy machine with proton 150 MeV FFAG as a prototype Commissioning to accelerate up to ~15 MeV is done. Tune.
NEUTRINO DETECTORS Cutting-Edge Accelerator Research for a Neutrino Factory and Other Applications Ajit Kurup for the FETS and UKNF Collaborations Cutting-Edge.
IDS-NF Accelerator Baseline The Neutrino Factory [1, 2] based on the muon storage ring will be a precision tool to study the neutrino oscillations.It may.
1 Introduction and overview of FFAG accelerators S. Machida CCLRC-ASTeC 7 February, ffag/machida_ ppt.
FFAG Nonscaling FFAGs for Hadron Therapy C. Johnstone, Fermilab FFAG08 Sept 1-5, 2008 University of Manchester Manchester, U.K. Fermilab.
FFAG Progress on Tune-stable Nonscaling FFAGs C. Johnstone, Fermilab FFAG08 Sept 1-5, 2008 University of Manchester Manchester, U.K. Fermilab.
FFAG’ J. Pasternak, IC London/RAL Proton acceleration using FFAGs J. Pasternak, Imperial College, London / RAL.
July PRISM Workshop,ICL Extraction in PAMELA, T.Yokoi Extraction in PAMELA Takeichiro Yokoi (JAI, Oxford University, UK)
EMMA, BASROC, Hadron Therapy and ADSRs Roger Barlow STFC Cockcroft Review Feb 11 th 2009.
Accelerators: The Final Frontier? Ken Peach John Adams Institute for Accelerator Science University of Oxford & Royal Holloway University of London October.
ICHEP Conference Amsterdam 31st International Conference on High Energy Physics 24  31 July 2002 Gail G. Hanson University of California, Riverside For.
ADSR Inst.July 2009 From PAMELA to ADSR, T.Yokoi From PAMELA to ADSR Takeichiro Yokoi (JAI)
The Australian Hadron Therapy and Research Facility.
10/21/2009Dr. Carol Johnstone1 Workshop Charge: Dr. Carol Johnstone Sept 21-25, 2009 Fermilab.
Introduction to NS-FFAGs and EMMA Rob Edgecock STFC Rutherford Appleton Laboratory.
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
PSI, Zurich February 29 – March Session classification : Accelerator Concepts Tuesday, March 1, 2016 Summary Vyacheslav Yakovlev Fermilab, USA.
A Compact FFAG for Radioisotope Production D. Bruton R. Barlow, R. Edgecock, and C.J. Johnstone.
Particle Physics Group Meeting January 4 th – 5 th 2010 Commissioning EMMA, the Worlds First Non Scaling Fixed Field – Alternating Gradient Accelerator.
PSI, Zurich February 29 – March Session classification : Accelerator Concepts Tuesday, March 1, 2016 Introduction Vyacheslav Yakovlev Fermilab,
UK Neutrino Factory Conceptual Design
J-PARC main ring lattice An overview
Synchrotron Ring Schematic
Muon Acceleration in a Neutrino Factory
FFAG Accelerator Proton Driver for Neutrino Factory
Explanation of the Basic Principles and Goals
Presentation transcript:

A new accelerator for advanced research and cancer therapy Ken Peach John Adams Institute for Accelerator Science University of Oxford and Royal Holloway University of London Princeton 11 th October 2007

Ken PeachJohn Adams Institute11 x 072 Outline Introduction (Accelerators & Particle Physics) The Neutrino Factory (Why? The Muon Acceleration Challenge) The ns-FFAG Accelerator (non-scaling Fixed-Field Alternating Gradient) EMMA Charged Particle Therapy (CPT) (proton and light-ion cancer treatment) PAMELA Summary

Ken PeachJohn Adams Institute11 x 073 Introduction There are more than 17,000 particle accelerators (> a few MeV) worldwide –Most are used in medicine Linacs, cyclotrons, some synchrotrons… –Next most common in industry Ion implantation etc –Synchrotron Radiation Sources Mostly synchrotrons, coming soon - linacs –Neutron and radionuclide sources Linacs, cyclotrons, synchrotrons, something weird and –For particle physics! A few big synchrotrons (& colliders) –Often with Linacs at the front end And coming soon (maybe) the ILC

Ken PeachJohn Adams Institute11 x 074 Classical Accelerator Types TypeMagnetic Field RFRadius BetatronVariable  Fixed CyclotronFixed Variable SynchrotronVariable Fixed FFAGFixed ~Fixed Linear acccelerators (Linacs)   + assorted others – electrostatic, RFQs etc … + new ideas (laser-plasma for example) …

Ken PeachJohn Adams Institute11 x 075 The Bleeding Edge? Medical accelerators –Mainly linacs and cyclotrons Research accelerators –Mainly synchrotrons Particle Physics applications –Better synchrotrons (LHC) –Better linacs (ILC) Why do we need anything new? –Because life presents new challenges!

Ken PeachJohn Adams Institute11 x 076 HiggsBosonHiggsBoson? Force Carriers Z Z boson W W boson  photon g gluon Generations of matter Generations of matter   -neutrino  tau b bottom t top III   -neutrino  muon s strange c charm II e e-neutrino e electron d down up uI Leptons Quarks Particles and Forces Each with its own ‘antiparticle’ © Brian Foster

Ken PeachJohn Adams Institute11 x 077 The Standard Model The Parameters 6 quark masses –m u, m c, m t –m d, m s, m b 3 lepton masses –m e, m , m  2 vector boson masses –M w, M Z (m , m g =0) 1 Higgs mass –M h 3 coupling constants –G F, ,  s 3 quark mixing angles –  12,  23,  13 1 quark phase – 

Neutrino Factory The “ultimate” neutrino facility

Ken PeachJohn Adams Institute11 x 079 The Standard Model The Parameters 6 quark masses –m u, m c, m t –m d, m s, m b 3 lepton masses –m e, m , m  2 vector boson masses –M w, M Z (m , m g =0) 1 Higgs mass –M h 3 coupling constants –G F, ,  s 3 quark mixing angles –  12,  23,  13 1 quark phase –  Neutrino sector Neutrino masses identically 0!!!!

Ken PeachJohn Adams Institute11 x 0710 Neutrino Mixing Parameters of neutrino oscillation 1 absolute mass scale 2 squared mass diffs 3 mixing angles 1 phase 2 Majorana phases solarAtmospheric Majorana 3G c ij =cos  ij s ij =sin  ij 22

Ken PeachJohn Adams Institute11 x 0711 a =2  2 G F n e E =  E Where is the electron density ;  is the density (g/cm 3 ) ; E is the neutrino energy (GeV ) Why is it hard to measure the parameters? (Richter: hep-ph/ ) c ij =cos  ij, s ij =sin  ij

Ken PeachJohn Adams Institute11 x 0712 What to Measure? Neutrinos e disappearance e   appearance e   appearance  disappearance   e appearance    appearance … and the corresponding antineutrino interactions Note: the beam requirements for these experiments are: high intensityknown flux known spectrum known composition (preferably no background)

Ken PeachJohn Adams Institute11 x 0713 CP-violation FNAL Feasibality Study 1

Ken PeachJohn Adams Institute11 x 0714 A Neutrino Factory is … … an accelerator complex designed to produce >10 20 muon decays per year directed at a detector thousands of km away Muon Acceleration … need to accelerate muons very quickly GeV,   ~0.1msec]

Ken PeachJohn Adams Institute11 x 0715 Neutrino Factory cost drivers High Power proton drivers –MW power, ns pulses RLA or FFAG? –Which is cheaper? RF –30% of the cost? Cooling –How much? (20% of the cost?) BNL Feasibality Study 2

The non-scaling FFAG Accelerator Fixed-Field Alternating Gradient

Ken PeachJohn Adams Institute11 x 0717 Fixed Field Alternating Gradient accelerators Fixed-Field (like a cyclotron) –Rapid acceleration possible –Rapid cycling possible Alternating Gradient (like a synchrotron) –Focussing!!!! Small (er) magnets/beam pipe/vacuum system … and large acceptance The best of both worlds! –So why is the world not full of FFAGs? TypeMagnetic FieldRFRadius FFAGFixed ~Fixed

Ken PeachJohn Adams Institute11 x 0718 Early FFAGs ( ) MURA built several electron FFAGs in the 1950s 20 to 400 keV machine ChandrasekharBohr Radial sector Spiral sector Large complicated magnets c.f. Cyclotron – large simple magnets c.f. Synchrotron – small simple magnets

Ken PeachJohn Adams Institute11 x 0719 Newer FFAG’s (post-2000) The Japanese have built two “proof of principle” proton FFAGs 500 keV proton KEK150 MeV proton KEK

Ken PeachJohn Adams Institute11 x 0720 … but … Why? LARGE COMPLICATED … the magnets are LARGE and COMPLICATED Why does k have to be so large? 1.Larger k means stronger focussing 2. k > 0 means horizontal focussing –This means that the average field increases with radius 3.The momentum compaction   1/(k+1) –Large momentum bite  small orbit excursion Orbit excursion ~ 0.9m + where k >> 1

Ken PeachJohn Adams Institute11 x 0721 Scaling and non-scaling FFAGs where k >> 1 where k = 1 Linear Linear magnets! i.e. quadrupoles Invented in 1999

Ken PeachJohn Adams Institute11 x 0722 Simpler Magnets LARGE COMPLICATED … the magnets are LARGE and COMPLICATED SMALLSIMPLE … to something SMALL and SIMPLE r B (r)

Ken PeachJohn Adams Institute11 x 0723 The ns-FFAG Should combine the advantages of FFAGs –Fixed Field Fast cycling (limited essentially by RF) Simpler, cheaper power supplies No eddy-currents High intensity (pulsed, ~continuous) Low beam losses Easier maintenance and operation Lower stresses –Strong Focussing Magnetic ring Variable energy extraction Higher energies (than cyclotrons) Different ion species possible with relative ease of construction

Ken PeachJohn Adams Institute11 x 0724 … so … where is the catch? Variable tune! Tune ~    c Must cross resonances

Ken PeachJohn Adams Institute11 x 0725 Beam Acceleration coherentResonance is a coherent effect –Can fast acceleration circumvent the resonances? If the momentum changes by a large amount during a single turns, is it possible to leap-frog over the resonance? –Small variation of the path length with momentum (small momentum compaction) Fixed radio-frequency cavities? 10MeV 20MeV |df/f|~0.1% 0.1ns Plots for EMMA

Ken PeachJohn Adams Institute11 x 0726 Does it work? We do not know! –There is no “no-go” theorem Need for a “proof of principle” demonstrator –EMMA Electron Model for Many Applications –Originally Electron Model for Muon Acceleration Funding obtained in the UK to design and build a EMMA – the world’s first non-scaling FFAG accelerator!

Ken PeachJohn Adams Institute11 x 0727 Objectives of the CONFORM Project 1.Show the non-Scaling Fixed-Field Alternating Gradient Accelerators work Build an Electron Model (EMMA) Design a prototype Charged Particle Therapy machine based on ns-FFAGs Protons and carbon ions 2.Develop applications of ns-FFAGs

Ken PeachJohn Adams Institute11 x 0728 EMMA Parameters 42 identical straight length mm Long drift mm F Quad mm Short drift mm D Quad mm

Ken PeachJohn Adams Institute11 x 0729 Location of EMMA Daresbury

Ken PeachJohn Adams Institute11 x 0730 EMMA at the After Neil Bliss ERLP Parameters

Ken PeachJohn Adams Institute11 x 0731 EMMA: Lattice & Magnets B0B0 xx Magnet linear slide After Neil Bliss

Ken PeachJohn Adams Institute11 x 0732 Diagnostics, injection & extraction After Rob Edgecock

Ken PeachJohn Adams Institute11 x 0733 Status of EMMA Funded! (~$10M) –Started 1 st April 2007 Lattice- fixed Component design- ongoing –Prototype quads being measured now Final design- complete Jan 08 Construction- complete Jul 09 Beam studies- until Sep 10 –At least … After Tkeichiro Yokoi

Ken PeachJohn Adams Institute11 x 0734 CONFORM

PAMELA Charged Particle Therapy (CPT) BASROC & CONFORM

Ken PeachJohn Adams Institute11 x 0736 Incidence of Cancer in the UK 13.5% probability, all types (except skin cancer) –Around half are associated with specific risks –Statistically, some will be close to sensitive tissue and difficult to treat surgically or chemically Source: Cancer Research UK

Ken PeachJohn Adams Institute11 x 0737 Why use protons? After Bleddyn Jones X-Rays Protons

Ken PeachJohn Adams Institute11 x 0738 Why use Carbon? Daniela Schulz-Ertner, Heiddelberg

An important statistic “ Radiotherapy remains a mainstay in the treatment of cancer. Comparison of the contribution towards cure by the major cancer treatment modalities shows that of those cured, 49% are cured by surgery, 40% by radiotherapy and 11% by chemotherapy”. RCR document BFCO(03)3, (2003). Chemotherapy provides by far the smallest contribution towards cancer cure yet is much more expensive than radiotherapy and generates a disproportionately large research and media interest. Roger Dale, Hammersmith Hospital and Imperial College

What is RBE? RBE = Relative Biological Effectiveness. A measure of the biological “potency” of a particular type of radiation relative to that of a reference radiation. Reference radiation (conventional x-rays) has RBE = 1 For a given biological end-point: Proton RBEs: ~ 1.1 Neutron RBEs: Carbon ion RBEs: Roger Dale, Hammersmith Hospital and Imperial College

The concept and definition of RBE are both straightforward. Unfortunately…. Even for a particular type of radiation, RBE is not fixed. Its value depends on: a) The size of the dose used at each treatment b) The chosen biological end-point c) The nature of the irradiated tissue Roger Dale, Hammersmith Hospital and Imperial College

Ken PeachJohn Adams Institute11 x 0742 CPT facilities operating & planned

Ken PeachJohn Adams Institute11 x 0743 Hadron Therapy in Chiba (Japan) Borrowed from Rob Edgecock

Ken PeachJohn Adams Institute11 x 0744 Cancer of the Kidney Stage I: TIa N0 M0 80GyE / 16fr. /4wks 治療前 1 year 2 years 3 years 4 years

Ken PeachJohn Adams Institute11 x 0745 Prostate Cancer Results

Ken PeachJohn Adams Institute11 x 0746 We can do better

Monitoring and Control :Key issues for medical applications time Integrated current Synchrotron & cyclotron time Integrated current FFAG Dose uniformity should be < ~2%  To achieve the uniformity, precise intensity modulation is a must Beam of FFAG is quantized.  Active intensity control at the injection level and precise loss control are indispensable. New approach to medical accelerator control is required in PAMELA (New postdoc is employed for the issue) SOBP is formed by superposing Bragg peak Gate width controls dose Step size controls dose intensity modulation Takeichiro Yokoi

Ken PeachJohn Adams Institute11 x 0748 … much better

Ken PeachJohn Adams Institute11 x 0749 The requirements There are obvious potential benefits from proton/light ion therapy –Need to maximise the benefits Requirements –Rapid variable energy extraction –Rapid variable transverse spot scanning –Variable ion species –Accurate dose measurements Flux control

Ken PeachJohn Adams Institute11 x 0750 Synchrotron Cyclotron FFAG Intensity (>100nA) LowPlenty Plenty 1-16nA >100nA MaintenanceNormal HardNormal Extraction eff Good Poor Good OperationNot easy Easy Easy Ions Yes No Yes Variable energy Yes No Yes Multi-extractionPossible No Yes After Y.Mori KEK/Kyoto Advantages of FFAG in Charged Particle Therapy

Ken PeachJohn Adams Institute11 x 0751 Ns-FFAG machine

Ken PeachJohn Adams Institute11 x 0752 PAMELA Preliminary ideas –Cyclotron ~20 MeV (or 8 MeV – 2 ring) –1 or 2 ns-FFAG proton rings 20 MeV  250 MeV (1 ring) 8 MeV  31 MeV & 31 MeV  250 MeV (2 ring) –+ 1 Ion ring 69 MeV/u  450 MeV/u –(proton ring equivalent to 69 MeV/u Carbon)

Ken PeachJohn Adams Institute11 x 0753 Injection and Extraction Small beam excursion of NS-FFAG makes energy variable beam extraction easier  Unique feature for fixed field accelerator However, large tune change requires phase adjustment mechanism in injection & extraction  multi-kicker system QD QF Kicker#2 Kicker#1 Septum ∆p/p=+0.0 Circulating Septum boundary By changing the field strength and direction, beam position in phase space can be adjusted Example of beam extraction (PAMELA)

Ken PeachJohn Adams Institute11 x 0754 Superconducting FFAG Gantries Fixed field of 3.7T Transports MeV/u Length ~15m D Trbojevic/BNL

Ken PeachJohn Adams Institute11 x 0755 BASROC

Ken PeachJohn Adams Institute11 x 0756 Summary Non-scaling FFAG accelerators are: –New –Untried –Interesting for Neutrino physics Cancer therapy –And other applications »Spallation neutron sources, muon sources »Accelerator driven reactors, nuclear waste disposal We will know in ~3 years if they work –Let us hope that they do … they could be very useful devices …